Lineage Cell Therapeutics, Inc. (LCTX) Contract with Customer, Liability, Noncurrent USD 2022 - 2023

Historical data

Taxonomy & unit: us-gaap: USD
Description: Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.
Summary: Lineage Cell Therapeutics, Inc. quarterly Contract with Customer, Liability, Noncurrent history and growth rate from 2022 to 2023.
Lineage Cell Therapeutics, Inc. Contract with Customer, Liability, Noncurrent for the quarter ending September 30, 2023 was $21.2 M.

Contract with Customer, Liability, Noncurrent, Quarterly (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2023	$21.2 M			Sep 30, 2023	10-Q	2023-11-09
Q4 2022	$27.7 M			Dec 31, 2022	10-Q	2023-11-09

* An asterisk sign (*) next to the value indicates that the value is likely invalid.